VNDA R&D to Revenue
Vanda Pharmaceuticals Inc · R&D to Revenue
VNDA R&D to Revenue
Latest reported50.56%period ending
VNDA FY R&D/Revenue (21904.01% → 50.56%)
Latest values, visible window
High-resolution chart · PNG
VNDA r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 50.5638% | |
| 37.4454% | |
| 39.879% | |
| 33.717% | |
| 28.0491% | |
| 22.3949% | |
| 21.4135% | |
| 22.5738% | |
| 23.3501% | |
| 19.9675% | |
| 26.5135% | |
| 38.3396% | |
| 83.2079% | |
| 138.8639% | |
| 92.7279% | |
| 35.0312% | |
| 305.0735% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 21,904.0112% |